We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

44 hedge funds and large institutions have $107M invested in Fibrocell Science Inc. in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,933% more call options, than puts

Call options by funds: $61K | Put options by funds: $3K

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

4% less funds holding

Funds holding: 4644 (-2)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

25% less capital invested

Capital invested by funds: $142M → $107M (-$35.2M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
12
Increased
13
Reduced
13
Closed
14
Calls
$61K
Puts
$3K
Net Calls
+$58K
Net Calls Change
-$23K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$62.4M +$1.49M +26,667 +3%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$14.4M
Jennison Associates
3
Jennison Associates
New York
$11M -$733K -13,139 -7%
MP
4
MSD Partners
New York
$6.89M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.19M +$113K +2,023 +6%
CCA
6
Catalyst Capital Advisors
New York
$1.51M +$1.41M +25,246 New
BGA
7
Belmont Global Advisors
Texas
$1.06M -$761K -13,646 -44%
Northern Trust
8
Northern Trust
Illinois
$749K -$119K -2,137 -15%
HVC
9
Healthcare Value Capital
New Jersey
$629K +$186K +3,333 +46%
BCM
10
Bridgeway Capital Management
Texas
$522K +$36.5K +654 +8%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$495K -$51.6K -925 -10%
Citigroup
12
Citigroup
New York
$466K +$117K +2,096 +37%
TMC
13
Trellus Management Company
Florida
$440K +$251K +4,503 +158%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$395K -$274K -4,915 -43%
PP
15
Paloma Partners
Connecticut
$383K +$357K +6,396 New
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$379K +$353K +6,333 New
FSA
17
Franklin Street Advisors
North Carolina
$376K +$93.7K +1,680 +37%
Bank of America
18
Bank of America
North Carolina
$354K +$330K +5,911 +73,888%
BFA
19
BlackRock Fund Advisors
California
$286K -$2.07M -37,139 -89%
SC
20
Saiers Capital
New York
$282K
COPPSERS
21
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$256K +$239K +4,278 New
Goldman Sachs
22
Goldman Sachs
New York
$248K +$75.5K +1,353 +49%
LP
23
LMR Partners
United Kingdom
$194K +$181K +3,235 New
Morgan Stanley
24
Morgan Stanley
New York
$157K +$121K +2,164 +480%
SIP
25
Stoneridge Investment Partners
Pennsylvania
$119K -$1.9K -34 -2%

FCSC Hedge Fund Activity: Q2 2014 in Review

44 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q2 2014, worth a combined $107M — down 25% from $142M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of FCSC and 12 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 13 added.

The largest buyer was Third Security, adding an estimated $1.49M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.07M.

  • 44 institutional investors held Fibrocell Science Inc. (FCSC) as of Q2 2014, down from 46 in Q1 2014.
  • Funds reported $107M of Fibrocell Science Inc. stock for Q2 2014, down 25% quarter-over-quarter.
  • 12 funds opened new Fibrocell Science Inc. positions in Q2 2014 and 14 closed out, a net change of -2 holders.
  • The largest Fibrocell Science Inc. buyer in Q2 2014 was Third Security, an estimated $1.49M added.
  • The largest Fibrocell Science Inc. seller in Q2 2014 was BlackRock Fund Advisors, an estimated $2.07M sold.

Based on aggregated 13F filings for Q2 2014.